MedTrace Logo

Lupus and Observance

NCT03019926 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2019-08-01

No results posted yet for this study

Summary

A poor therapeutic observance is described between 3 and 76% cases in systemic lupus. It is associated with an increased risk of relapses, hospitalizations, morbidity and poor renal prognosis.

New treatment protocols exist and are indicated in second intention in case of good compliance. An assessment of therapeutic adherence is therefore essential.

Patients with systemic lupus diagnosed for at least 6 months, or skin lupus, who have been prescribed with Plaquenil (hydroxychloroquine), will be included in the study.

The study primary objective is to determine risk factors for non-observance

The secondary objectives are to:

* Measure the observance rate of patients with systemic lupus in Martinique.
* Describe the parameters that influence observance: evaluation of the disease and associated comorbidities, psychosocial assessment, assessment of the doctor-patient relationship, evaluation of the disease representations.

Conditions

  • Systemic Lupus, Skin Lupus

Interventions

BIOLOGICAL

Hydroxychloroquine dosage

Blood sample from a 6 ml tube, performed in the common practice.

Sponsors & Collaborators

  • University Hospital Center of Martinique

    lead OTHER

Principal Investigators

  • Katlyne POLOMAT, MD · CHU of Martinique

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-19
Primary Completion
2018-07-19
Completion
2018-07-19

Countries

  • France

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03019926 on ClinicalTrials.gov